Tweet

Medipattern Featured on the Next Biggest Winner

TORONTO, ONTARIO — (Marketwire) — 04/18/12 — Attention: Business/Financial Editors

The Medipattern Corporation (“Medipattern” or the “Company”) (TSX VENTURE: MKI), will be featured on “The Next Biggest Winner” airing on iChannel TV on Thursday, April 19 at 7:00 PM EST. You can listen to the segment, featuring Medipattern CEO Jeff Collins, by visiting . The Next Biggest Winner is a television interview series for Canadian investors dedicated to identifying companies poised for growth. More information is listed at the show-s web site http://www.thenextbiggestwinner.com/episode-schedule/.

“Medipattern-s proprietary new FDA approved 3D carotid rendering product Visualize:Vascular technology, enables practitioners to better understand the lumen in carotid arteries, aiding in the determination of who should go into watchful medical observation and who requires surgery, thereby providing a valuable life-saving tool for patients. Furthermore, the sooner luminal reduction (plaque) is detected in the patient, the sooner the patient can be treated with medication such as statins or some other options,” stated Jeff Collins, President and CEO of Medipattern. “Long term, it could be that the time taken to do a standard carotid exam could be reduced to a fraction of the time by utilizing the Visualize:Vascular protocol.”

“The economics of using Visualize:Vascular product within a medical practice are obvious because the practice is being reimbursed by insurance providers. The bottom line is that there is value for everyone along the way, which is why we continue to add more sites to our client roster,” concluded Mr. Collins.

We welcome Lenox Hill Radiology (four sites), East Suffolk Cardiology (part of the SUNY system at Stony Brook) and Massapequa Heart (part of the North Shore – LIJ system) to the Medipattern family. Medipattern continues to expand its network of clinics in the USA where Visualize:Vascular is available. “Scanning volumes continue to rise week over week as the practices come on line,” added Mr. Collins.

About the Medipattern Corporation:

Medipattern® is a pioneer in the development of imaging software solutions that help medical practitioners to better understand lesions and critical anatomy. Medipattern uses its Cadenza technology to process images, finding the salient region of interest and presenting them in 2D and 3D formats that enhance the reader-s perception. For more information, please visit the Company-s website: .

Medipattern® and B-CAD® are registered trademarks of The Medipattern Corporation. Visualize:Vascular and Cadenza are trademarks of the Medipattern Corporation. SonoCine is a registered trademark of SonoCine, Inc.

Forward-looking statements

This document contains forward-looking statements relating to Medipattern-s performance, operations, or business environment. These statements are based on what we believe are reasonable assumptions given currently available information and our understanding of Medipattern-s current activities. We have tried, whenever possible, to identify these forward-looking statements using words such as “anticipates,” “believes,” “estimates,” “expects,” “plans,” “intends,” “potential”, and similar expressions. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict or control. A number of factors could cause actual outcomes and results to differ materially from those expressed in forward-looking statements. These factors include but are not limited to those set forth in the Company-s corporate filings, (posted at ). In addition, these forward-looking statements relate to the date on which they are made. The Company disclaims any intention or obligation to update or revise any forward-looking statements for any reason. Readers should not rely on forward-looking statements.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contacts:
The Medipattern Corporation
Jeff Collins
CEO
(416) 744-0009 ext. 224

Spinnaker Capital Markets Inc.
Kevin O-Connor
(416) 962-3300 ext. 226